Irina Bobolea

1.8k total citations
52 papers, 767 citations indexed

About

Irina Bobolea is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Irina Bobolea has authored 52 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 23 papers in Pulmonary and Respiratory Medicine and 13 papers in Pharmacology. Recurrent topics in Irina Bobolea's work include Asthma and respiratory diseases (27 papers), Respiratory and Cough-Related Research (16 papers) and Drug-Induced Adverse Reactions (13 papers). Irina Bobolea is often cited by papers focused on Asthma and respiratory diseases (27 papers), Respiratory and Cough-Related Research (16 papers) and Drug-Induced Adverse Reactions (13 papers). Irina Bobolea collaborates with scholars based in Spain, Poland and Germany. Irina Bobolea's co-authors include Santiago Quirce, Pilar Barranco, Rosario Cabañas, Ana Fiandor, Nieves Prior, Teresa Bellón, Ebymar Arismendi, M C López-Serrano, Victoria del Pozo and Jesús Jurado‐Palomo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Irina Bobolea

48 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irina Bobolea Spain 17 373 281 187 171 110 52 767
K.‐U. Min South Korea 16 415 1.1× 206 0.7× 192 1.0× 113 0.7× 67 0.6× 23 719
Mustafa Erkoçoğlu Türkiye 15 164 0.4× 113 0.4× 220 1.2× 170 1.0× 136 1.2× 53 640
Francesca Racca Italy 15 461 1.2× 209 0.7× 217 1.2× 43 0.3× 80 0.7× 35 819
Suna Büyüköztürk Türkiye 20 334 0.9× 97 0.3× 360 1.9× 234 1.4× 222 2.0× 87 1.1k
Özlem Cavkaytar Türkiye 17 421 1.1× 107 0.4× 572 3.1× 149 0.9× 207 1.9× 51 1.0k
Gönül Adalıoğlu Türkiye 18 518 1.4× 289 1.0× 396 2.1× 57 0.3× 123 1.1× 36 918
Ayfer Tuncer Türkiye 20 469 1.3× 232 0.8× 596 3.2× 126 0.7× 237 2.2× 49 1.2k
Betül Büyüktiryaki Türkiye 19 282 0.8× 93 0.3× 585 3.1× 208 1.2× 224 2.0× 76 966
Yun‐Jeong Bae South Korea 15 148 0.4× 143 0.5× 59 0.3× 142 0.8× 68 0.6× 27 567
J Paupe France 13 155 0.4× 165 0.6× 282 1.5× 187 1.1× 165 1.5× 127 796

Countries citing papers authored by Irina Bobolea

Since Specialization
Citations

This map shows the geographic impact of Irina Bobolea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irina Bobolea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irina Bobolea more than expected).

Fields of papers citing papers by Irina Bobolea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irina Bobolea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irina Bobolea. The network helps show where Irina Bobolea may publish in the future.

Co-authorship network of co-authors of Irina Bobolea

This figure shows the co-authorship network connecting the top 25 collaborators of Irina Bobolea. A scholar is included among the top collaborators of Irina Bobolea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irina Bobolea. Irina Bobolea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
González‐Barcala, Francisco Javier, Irina Bobolea, Javier Domínguez‐Ortega, et al.. (2024). Time is lung: higher preservation of lung function in severe asthma patients after earlier mepolizumab treatment. ERJ Open Research. 11(1). 211–2024. 1 indexed citations
3.
Pozo, Victoria del, Irina Bobolea, Manuel J. Rial, et al.. (2024). Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases. Frontiers in Immunology. 14. 1310211–1310211. 8 indexed citations
4.
Bobolea, Irina, et al.. (2024). Phenotyping Asthma Exacerbations: One Step Further in the Management of Severe Asthma. Journal of Investigational Allergology and Clinical Immunology. 35(1). 1–11. 3 indexed citations
5.
Bobolea, Irina, Jan Hagemann, Marek Sanak, Ludger Klimek, & Joaquim Mullol. (2024). Current Goals of NSAID-ERD Management: Patient-Centered Approaches Involving NSAID Desensitization With and Without Biologics. The Journal of Allergy and Clinical Immunology In Practice. 12(11). 2934–2944. 2 indexed citations
6.
Bobolea, Irina, et al.. (2023). Molecular T2 asthma phenotypes are stable but heterogeneous: the usefulness of periostin for endotyping. SHILAP Revista de lepidopterología. 4. 1205115–1205115. 4 indexed citations
7.
Bobolea, Irina & César Picado. (2022). Aspirin Desensitization in NERD in the Era of Biologics: First or Last Resource?. Current Treatment Options in Allergy. 9(2). 91–106. 1 indexed citations
8.
Bobolea, Irina, et al.. (2022). Weight Loss and Vitamin D Improve Hyporesponsiveness to Corticosteroids in Obese Asthma. Journal of Investigational Allergology and Clinical Immunology. 33(6). 464–473. 10 indexed citations
9.
Roca‐Ferrer, Jordi, Joaquim Mullol, Antonio Valero, et al.. (2022). Differences in Inflammatory Cytokine Profile in Obesity-Associated Asthma: Effects of Weight Loss. Journal of Clinical Medicine. 11(13). 3782–3782. 17 indexed citations
10.
Arismendi, Ebymar, et al.. (2022). Eosinophilic Sialodochitis: A Rare Comorbidity of Severe Asthma. Journal of Investigational Allergology and Clinical Immunology. 33(2). 139–140. 3 indexed citations
11.
Martínez‐Rivera, Carlos, Astrid Crespo‐Lessmann, Ebymar Arismendi, et al.. (2021). Challenges for asthma units in response to COVID-19: a qualitative group dynamics analysis. Journal of Asthma. 59(6). 1195–1202. 3 indexed citations
12.
Bobolea, Irina, Victoria del Pozo, Verónica Sanz, et al.. (2018). Aspirin desensitization in aspirin-exacerbated respiratory disease: New insights into the molecular mechanisms. Respiratory Medicine. 143. 39–41. 11 indexed citations
13.
Llano, Luís Pérez de, Borja G. Cosío, Amanda Iglesias, et al.. (2018). Mixed Th2 and non-Th2 inflammatory pattern in the asthma–COPD overlap: a network approach. International Journal of COPD. Volume 13. 591–601. 45 indexed citations
14.
Grande, Carlos, et al.. (2017). Modern challenges of allergic bronchopulmonary aspergillosis diagnosis and management. Annals of Allergy Asthma & Immunology. 119(1). 93–94. 1 indexed citations
15.
Quirce, Santiago, Irina Bobolea, Javier Domínguez‐Ortega, & Pilar Barranco. (2014). Futuras terapias biológicas en el asma. Archivos de Bronconeumología. 50(8). 355–361. 12 indexed citations
16.
Quirce, Santiago, Irina Bobolea, & Pilar Barranco. (2013). Asma: actualización terapéutica. Medicina Clínica. 142(7). 317–322. 1 indexed citations
17.
Barranco, Pilar, J. Delgado, Irina Bobolea, et al.. (2012). Asma, obesidad y dieta. Nutrición Hospitalaria. 27(1). 138–145. 6 indexed citations
18.
Quirce, Santiago, Irina Bobolea, & Pilar Barranco. (2012). Emerging drugs for asthma. Expert Opinion on Emerging Drugs. 17(2). 219–237. 12 indexed citations
19.
Bobolea, Irina, Pilar Barranco, Carlos Pastor‐Vargas, et al.. (2010). Arginine Kinase from the Cellar Spider <i>(Holocnemus pluchei): </i>A New Asthma-Causing Allergen. International Archives of Allergy and Immunology. 155(2). 180–186. 28 indexed citations
20.
Martín‐Muñoz, M.F., et al.. (2010). Bee pollen: a dangerous food for allergic children. Identification of responsible allergens. Allergologia et Immunopathologia. 38(5). 263–265. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026